Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Items 801–900 of 1,000
Takahashi, K., Nakamura, A., Miyoshi, H., Nomoto, H., Kameda, H., Cho, K. Y., Nagai, S., Shimizu, C., Taguri, M., Terauchi, Y., et al. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0332 · Cited by 3
Clinical evaluation of pituitary insufficiency in adult population
Beysel, S., Çalışkan, M., Kızılgül, M., Kan, S., Özbek, M., & Çakal, E. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1908-19 · Cited by 3
Molitch, M. E. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70224-5 · Cited by 2
Self-citationZhou, P., & Lv, Q. (2021) · PubMed Central · Cited by 2
Ummah, K., & Adi, S. (2021) · Current Internal Medicine Research and Practice Surabaya Journal · doi:10.20473/cimrj.v2i2.26284 · Cited by 3
Growth hormone deficiency in childhood brain tumors and acute lymphoblastic leukemia survivors
Pavlova, M. G., Tselovalnikova, T., Евгеньевна, Ю. А., Golounina, O. O., Zilov, A. V., Mazerkina, N. A., Zheludkova, O., & Fadeev, V. V. (2022) · Obesity and metabolism · doi:10.14341/omet12786 · Cited by 3
Wass, J. A. H., Owen, K. R., & Turner, H. E. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199644438.003.0002 · Cited by 2
Contribution of Dynamic and Genetic Tests for Short Stature Diagnosing: A Case Report
Biagetti, B., Valenzuela, I., Campos-Martorell, A., Campos, B., Hernández, S., Giralt, M., Díaz-Troyano, N., Iniesta-Serrano, E., Yeste, D., & Simó, R. (2023) · Diagnostics · doi:10.3390/diagnostics13132259
Zhou, Z., Luo, Y., Li, K., Zhong, S., Zhu, Y., Yang, H., Wang, L., Chen, S., Duan, L., Gong, F., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03583-5 · Cited by 3
Daloğlu, O. O., Ünal, M. Ç., Kemaloğlu, C. A., Bolattürk, Ö. F., Özyazgan, İ., Tanrıverdi, F., Çoruh, A., & Keleştimur, F. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02349-8 · Cited by 2
“GST is accepted as a good alternative test for the diagnosis of GHD when GHRH is unavailable or there is a contraindication for ITT [18].”
BackgroundChoudhuri, R. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000154 · Cited by 2
Pituitary Evaluation in Patients with Low Prostate-Specific Antigen
Drincic, A., Nguyen, A.-T., Singh, S., Zena, M., Walters, R. W., Friedman, K., & Anderson, R. J. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0204 · Cited by 2
Hypothalamic Growth Hormone/IGF-1 Axis
Colao, A., Savastano, S., & Somma, C. D. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_5 · Cited by 2
Adult Growth Hormone Deficiency
Vaughan, T. B., Riley, K. O., & Blevins, L. S. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch5 · Cited by 2
Endocrine Complications in Childhood Cancer Survivors
Yuen, K. C. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-13832-9_26 · Cited by 1
Endocrine Disorders and the Cardiovascular System
Ghaemmaghami, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-80915-3.00001-6 · Cited by 1
Craniopharyngioma and Posttreatment Pituitary Dysfunction in Brain Tumors
Felicetti, F. C., Prencipe, N., Brignardello, E., & Arvat, E. (2017) · Endocrinology · doi:10.1007/978-3-319-38681-2_5-2 · Cited by 2
Sim, S. Y., & Ahn, M. B. (2023) · Sensors · doi:10.3390/s23156892 · Cited by 2
Arisaka, O., Koyama, S., Imataka, G., Naganuma, J., Arisaka, T., & Akatsuka, S. (2024) · Diseases · doi:10.3390/diseases12100251 · Cited by 1
“Adult GH deficiency (AGHD) is associated with increased visceral fat, dyslipidemia, premature atherosclerosis, reduced quality of life, and elevated mortality [10].”
BackgroundYang, H., Chen, M., Liu, S., Zhang, Y., Wang, L., Duan, L., Gong, F., Zhu, H., & Pan, H. (2024) · International Journal of Endocrinology · doi:10.1155/ije/9735508 · Cited by 1
Díez, J. J., Anda, E., Lesmes, I. B., González, C., Miguélez, M., Zugasti, A., & Fernández, A. (2025) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2025.101531 · Cited by 4
Tselovalnikova, T., Ponvilawan, B., Pavlova, M. G., Flanagan, C., Rakhra, S. S., & Drees, B. M. (2025) · Endocrine Oncology · doi:10.1530/eo-25-0025 · Cited by 2
Neuroendocrine dysfunction after TBI: A guide for the clinical neuropsychologist
Howell, S., & Masel, B. E. (2025) · The Clinical Neuropsychologist · doi:10.1080/13854046.2025.2537335 · Cited by 1
“Instead, surrogates and provocative testing of GH secretion are recommended by the Endocrine Society (Molitch et al., 2011; Tritos et al., 2015).”
Growth hormone deficiency in Cushing’s syndrome: an update on diagnosis and management
Tritos, N. A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2559673 · Cited by 1
Gasco, V., Cuboni, D., Siclari, S., Mocellini, F., Sibilla, M., Grottoli, S., Ghigo, E., & Maccario, M. (2025) · Biomedicines · doi:10.3390/biomedicines13112676 · Cited by 1
“In patients without formal evaluation of the somatotropic axis by stimulation testing, the presence of at least three other pituitary deficiencies was considered sufficient for the diagnosis of GHD, even in the absence of a stimulation test [61–64].”
A pharmacological profile of somapacitan for the treatment of growth hormone deficiency
Al-Rayess, H., & Miller, B. S. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2576103 · Cited by 1
“GH therapy was approved for adults with GHD in 1996 to improve body composition, bone health, cardiovascular risk factors, and quality of life [3,8].”
Vos, M. J., Postma, M. R., Lentjes, E. G. W. M., Habich-Reijntjes, L., Kelly, D., Kobold, A. C. M., Bocca, G., van der Klauw, M. M., van Beek, A. P., Kema, I. P., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag040 · Cited by 1
Yadav, P. K., Hamrahian, A. H., & Salvatori, R. (2026) · Pituitary · doi:10.1007/s11102-026-01654-0 · Cited by 1
Srilanchakon, K. (2026) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2026.101698 · Cited by 3
Gasco, V., Cuboni, D., Sibilla, M., Mocellini, F., Martinotti, A., Lucisano, D., Ghigo, E., Aimaretti, G., Grottoli, S., & Maccario, M. (2026) · Pituitary · doi:10.1007/s11102-026-01697-3 · Cited by 1
Krawzow, A., Peitzsch, M., Bastian, M., Postrach, T., Harms, L. J., Novikova, E., Eisenhofer, G., & Willenberg, H. S. (2026) · Endocrine Connections · doi:10.1530/ec-26-0261 · Cited by 1
Issues in Long-Term Management of Adults with Growth Hormone Deficiency
McGowan, A. N., & Gibney, J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-317-6_11 · Cited by 1
“These studies demonstrated that GH deficiency (GHD) in adults was associated with abnormal body composition, dyslipidaemia, reduced exercise capacity and strength, increased surrogate markers of cardiovascular risk, and impaired quality of life (for reviews, see [1–6]).”
BackgroundInfluentialPossible predictors for QOL improvement following GH replacement therapy in adult GHD
Shimatsu, A., Iwamoto, N., Tanaka, T., Teramoto, A., Taketsuna, M., Ihara, K., Funai, J., Irie, M., & Chihara, K. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0616 · Cited by 1
Adult GH deficiency - the value of IGF-I estimation
Boschetti, M. (2013) · Reviews in Endocrinology and Metabolism · doi:10.11138/rem/2013.1.2.067 · Cited by 1
Are patients in remission from Cushing's syndrome mentally healthy?
Boguszewski, C. L. (2013) · Clinical Endocrinology · doi:10.1111/cen.12278 · Cited by 1
Management of Adult with Childhood-Onset Growth Hormone Deficiency
Cook, D. M. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_8 · Cited by 1
Goedgezelschap, A., & Dejaeger, E. W. (2015) · Tijdschrift voor Gerontologie en Geriatrie · doi:10.1007/s12439-015-0152-2 · Cited by 1
Loh, H. H., Sukor, N., & Nor Azmi, K. (2015) · PubMed · Cited by 1
Gul, R. (2012) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.3309 · Cited by 1
Laboratory Diagnosis of Growth Hormone Deficiency in Adults
Yuen, K. C. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-28038-7_9 · Cited by 2
Obesity and Metabolic Disturbances in Adamantinomatous Craniopharyngioma Patients
Erfurth, E. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-51890-9_6 · Cited by 1
Medical Management for Pituitary Adenoma Patients
Hong, G. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-56691-7_21 · Cited by 1
Endocrine Disorders and the Cardiovascular System
Ghaemmaghami, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-51149-0.00032-8 · Cited by 1
Major predictors of growth hormone and cardiovascular risk: systematic review and meta-analysis
Ramirez, A. V. G. (2018) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2018.06.00193
Moriyama, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801028-0.00132-x · Cited by 1
Diagnosis of Growth Hormone Deficiency in Adults
Pekić, S., & POPOVIC, V. M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-317-6_9 · Cited by 3
Taguchi, T., Suzuki, A., & Takano, K. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0439 · Cited by 1
Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Vance, S. A., Zeidan, E., Henrich, V. C., & Sandros, M. G. (2016) · Journal of Visualized Experiments · doi:10.3791/53508-v · Cited by 1
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_7 · Cited by 2
The role of growth hormone for fertility in women with hypopituitarism
Chen, J., & Katznelson, L. J. (2022) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2022.101458 · Cited by 1
Hypophysenvorderlappen und Austestung der glandotropen Achsen
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Schneider, S. (2018) · Springer eBooks · doi:10.1007/978-3-662-55914-7_13 · Cited by 1
Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots
Krogh, J., Plomgaard, P., Frikke‐Schmidt, R., Velschow, S., Johannesen, J., Hilsted, L. M., Schrøder, M., & Feldt‐Rasmussen, U. (2023) · Endocrine Connections · doi:10.1530/ec-23-0087 · Cited by 1
Herpes Simplex Virus Diencephalitis Leading to Panhypopituitarism
Casey, C., O’Connor, A., Cronin, S., & Tuthill, A. (2023) · JCEM Case Reports · doi:10.1210/jcemcr/luad050 · Cited by 1
“As outlined in the Endocrine Society Clinical Practice Guideline “Evaluation and Treatment of Adult Growth Hormone Deficiency,” GH replacement offers significant benefit in body composition, with studies showing a decrease in total body fat content in response to GH therapy [9].”
BackgroundMetabolomics of Rare Endocrine, Genetic Disease: A Focus on the Pituitary Gland
Masood, A., Malkawi, A. K., Rahman, A. M. A., & Siaj, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-5162-8_8 · Cited by 1
Inna, M., Fuad, A., Mubarak, A., Khairan, A., Mamonto, A. M., & Rosihan (2023) · Technium Romanian Journal of Applied Sciences and Technology · doi:10.47577/technium.v17i.10054 · Cited by 1
Chronic heart failure: An appropriate clinical context to search for GH deficiency?
Cittadini, A., Luca, M. D., & Saccà, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.11.010 · Cited by 1
Yuen, K. C. J., Blevins, L. S., Clemmons, D. R., Faurby, M. D., Hoffman, A. R., Kelepouris, N., Kerr, J. M., Tarp, J. M., & Fleseriu, M. (2024) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s445495 · Cited by 1
“2,21,22,24,28 Given the likely under-recognition and under-treatment of AGHD and the consequent lack of understanding of its overall economic burden, methods for identifying individuals who are likely to have or to develop AGHD are needed.”
BackgroundMethodSelf-citationCriseno, S., Gleeson, H. K., Toogood, A. A., Gittoes, N. J. L., Topping, A. E., & Karavitaki, N. (2024) · Endocrine Connections · doi:10.1530/ec-23-0533 · Cited by 3
Yoshida, T., Baedke, J. L., Wang, H., Chen, Y., Yu, C. H., Wilson, C. L., Mulrooney, D. A., Dixon, S. B., Huang, I., Brinkman, T. M., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf156 · Cited by 3
Pan, L.-S., Xiong, Y.-T., Ye, Z.-C., Zhang, J., Deng, X., Wang, Q.-Y., & Hong, T. (2025) · Pituitary · doi:10.1007/s11102-025-01581-6 · Cited by 3
“Treatment-related adverse events reported in the literature were maintained within the 6%−7% range [ 63], predominantly manifesting as rash at the injection site, peripheral edema, joint stiffness and pain [ 64–66 ].”
Transition from Puberty to Adulthood
Gleeson, H. K. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-317-6_10 · Cited by 1
Álvarez‐Escolá, C., Fernández-Rodríguez, E., Recio‐Córdova, J. M., Bernabéu, I., & Fajardo, C. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.02.004 · Cited by 3
Marume, K., Arima, Y., Igata, M., Nishikawa, T., Yamamoto, E., Yamamuro, M., Tsujita, K., Tanaka, T., Kaikita, K., Hokimoto, S., et al. (2014) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2014.08.002 · Cited by 1
Hypophysenvorderlappen und Austestung der glandotropen Achsen
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Schneider, S. (2015) · Springer eBooks · doi:10.1007/978-3-662-47480-8_13 · Cited by 1
Thilmany, S., Mchirgui, L., Brunelle, C., Beauloye, V., Maiter, D. M., & Alexopoulou, O. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0620-8517 · Cited by 1
Dynamic Investigations and Diagnostic Testing
Yedinak, C. G., & Davies, K. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_15 · Cited by 3
Ain, Q. U., Noreen, Sheikh, W. H., Akhtar, H., Asif, N., Naz, S., & Naqvi, S. A. (2019) · doi:10.35248/2161-1009.19.8.379 · Cited by 1
Martínez, F. C., Ramos, Y. P., & Aballe, M. C. (2020) · Ciencia y Salud · doi:10.22206/cysa.2020.v4i2.pp13-20 · Cited by 1
Limited adherence to growth hormone replacement in patients with traumatic brain injury
Lithgow, K. C., Debert, C. T., & Kline, G. A. (2018) · Journal of Rehabilitation Medicine – Clinical Communications · doi:10.2340/20030711-1000008 · Cited by 1
Holmes, D. T., & Kline, G. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818277-2.00018-2 · Cited by 1
Heaton, A. L., Kelly, C. B., Rood, J. C., Tam, C. S., & Greenway, F. L. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2020.0109 · Cited by 4
Growth Hormone Deficiency in Young Cancer Survivors
Espiard, S., Jarfelt, M., & Johannsson, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-49140-6_7 · Cited by 1
Stable bone density in adolescents with severe growth hormone deficiency after six months off rhGH
Schweizer, R., Donner, J., von Lukowicz, B., Bauer, J. L., & Binder, G. (2020) · Bone · doi:10.1016/j.bone.2020.115771 · Cited by 2
Yovich, J. L., Zaidi, S. N. S. J. H., Nguyen, M. D., & Hinchliffe, P. M. (2020) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2020.13.3.0358 · Cited by 1
Heaney, A., de Oliveira, R. W. R., Bizzi, M. F., Corrêa, R. D. A., Pereira, M. C., Mol, S. S., Soares, B. S., McKenna, S. P., Ribeiro‐Oliveira, A., & Study Investigators (2020) · F1000Research · doi:10.12688/f1000research.27748.1 · Cited by 1
Hipopituitarismo. Panhipopituitarismo
Torres, N. P., Trifu, D. S., Montes, M. P. G., & Sánchez, E. A. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.06.022 · Cited by 1
Chernausek, S. D. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0591 · Cited by 1
Endocrine Complications of Head and Neck Surgery
Hu, M. I.-N., & Sherman, S. I. (2009) · Elsevier eBooks · doi:10.1016/b978-141604220-4.50012-2 · Cited by 1
Hypopituitarism, Causes, Diagnosis, Management and Mortality
Fountas, A., & Karavitaki, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64277-0 · Cited by 1
Janssen, J. A. M. J. L., van der Lely, A. J., Rogol, A. D., & Ioachimescu, A. G. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch26 · Cited by 1
ERKRANKUNGEN DER ENDOKRINEN ORGANE UND DES STOFFWECHSELS
Jung, N., Mayet, W.-J., Mertens, P. R., Meyer, J. S., Müller, O.-A., Pfeifer, M., Schellinger, P. D., Weiss, N., & Wendtner, C.-M. (2020) · Elsevier eBooks · doi:10.1016/b978-3-437-06282-7.50015-2 · Cited by 1
Giving mouth-to-mouth ventilations? This pocket mask could protect you from H.I.V. infection.
Juip, M., & Harned, J. C. (1988) · PubMed · Cited by 1
Rosenquist, K. J., & Kaiser, U. B. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch12 · Cited by 1
LA HORMONA DE CRECIMIENTO DURANTE EL PERÍODO DE TRANSICIÓN
Fideleff, H. L., Boquete, H., Suárez, M., & Azaretzky, M. (2014) · Actualidad Contable FACES
Deficiencia de hormona de crecimiento en el adulto ¿debe tratarse?
Boguszewski, C. L. (2010) · Revista Argentina de Endocrinología y Metabolismo
Marchisotti, F. G. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2007.tde-11032008-152540
Human growth hormone: a Paul Bunyan drug or a drug for Paul's bunion.
Griffing, G. T. (2007) · PubMed Central
van Dam, E. W. C. M. (2006) · Bijblijven · doi:10.1007/bf03059957 · Cited by 1
Lee, Y. A., Chung, H. R., Lee, S. M., Kim, J. H., Kim, J. H., Lee, S. H., Shin, C. H., & Yang, S. W. (2009) · Korean Journal of Pediatrics · doi:10.3345/kjp.2009.52.2.227
Low prevalence of growth hormone deficiency in Turkish patients with Hashimoto’s thyroiditis
Akın, S., Aydın, K., & Gürlek, Ö. A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0008-y
Indicaciones y secuencia de empleo de las pruebas funcionales hipofisarias. Criterios de valoración
Andújar, P., Fernández-Rodríguez, E., Bernabéu, I., & Casanueva, F. F. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70383-9
Tratamento com hormônio de crescimento: aspectos moleculares, clínicos e terapêuticos
Portes, E., Jorge, A. A. L., & Martinelli, C. E. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500001
Benefit of Growth Hormone Replacement in Adults Older than 60 Years
Arp, K., Schwahn, C., Friedrich, N., Kohlmann, T., Moock, J., Kołtowska‐Häggström, M., Nauck, M. A., Buchfelder, M., Wallaschofski, H., & Spielhagen, C. (2013) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2013.33024
Current and future perspectives on recombinant growth hormone for the treatment of obesity
Rixhon, M., Tichomirowa, M. A., Tamagno, G., Daly, A., & Beckers, A. M. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.1.75
Hipopituitarismos. Panhipopituitarismos. Deficiencias hipofisarias aisladas
Webb, S. M. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73165-5
The accuracy of the arginine growth hormone test in Parkinsonism
Abdo, W. F., Verbeek, M. M., & Bloem, B. R. (2008) · Movement Disorders · doi:10.1002/mds.22153 · Cited by 1
Cruz, E. C. (2011) · Institutional Repository of the University of Granada (University of Granada)
GH releasing peptide 2 test: the holy grail of testing GH deficiency?
Brabant, G. E. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0336
Antiaging Medicine: What Should We Tell Our Patients?
Perls, T. T. (2010) · Aging Health · doi:10.2217/ahe.10.11
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.